BR9915621A - Revestimento útil como um distribuidor de um ingrediente ativo em curativos e ataduras - Google Patents

Revestimento útil como um distribuidor de um ingrediente ativo em curativos e ataduras

Info

Publication number
BR9915621A
BR9915621A BR9915621-0A BR9915621A BR9915621A BR 9915621 A BR9915621 A BR 9915621A BR 9915621 A BR9915621 A BR 9915621A BR 9915621 A BR9915621 A BR 9915621A
Authority
BR
Brazil
Prior art keywords
distributor
active ingredient
dressings
useful
bandages
Prior art date
Application number
BR9915621-0A
Other languages
English (en)
Other versions
BR9915621B1 (pt
Inventor
Maria Aparecida De Carva Aledo
James J Meizanis
D Artagnan Silva De Oliveira
Fabio Eduardo Franca Rangel
Original Assignee
Johnson & Johnson Consumer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer filed Critical Johnson & Johnson Consumer
Publication of BR9915621A publication Critical patent/BR9915621A/pt
Publication of BR9915621B1 publication Critical patent/BR9915621B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A61F13/0203—Adhesive bandages or dressings with fluid retention members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
    • A61L2300/208—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/30—Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/428—Vitamins, e.g. tocopherol, riboflavin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings
    • A61L2300/608—Coatings having two or more layers
    • A61L2300/61—Coatings having two or more layers containing two or more active agents in different layers

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Patente de Invenção: <B>"REVESTIMENTO úTIL COMO UM DISTRIBUIDOR DE UM INGREDIENTE ATIVO EM CURATIVOS E ATADURAS"<D>. Os curativos da invenção compreendem pelo menos dois componentes: um substrato absorvente tendo uma primeira superfície de confrontação com a pele e uma segunda superfície oposta, e um revestimento descontínuo de uma composição semi-sólida tendo uma sensação semelhante a ung³ento sobrepondo uma porção da primeira superfície do dito substrato absorvente. O substrato absorvente é útil como um distribuidor passivo de pelo menos um ingrediente ativo que pode estar contido no mesmo. O revestimento descontínuo é essencialmente não aderente para a pele e é útil como um distribuidor ativo de pelo menos um ingrediente ativo que pode estar contido no mesmo. Em modalidades preferidas, o curartivo da invenção contém pelo menos um e mais preferivelmente pelo menos dois ingredientes ativos planejados para proporcionar benefício terapêutico para a pele.
BRPI9915621-0A 1998-11-24 1999-11-19 curativos. BR9915621B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19914298A 1998-11-24 1998-11-24
US09/199,142 1998-11-24
PCT/US1999/027552 WO2000030694A1 (en) 1998-11-24 1999-11-19 Coating useful as a dispenser of an active ingredient on dressings and bandages

Publications (2)

Publication Number Publication Date
BR9915621A true BR9915621A (pt) 2001-08-14
BR9915621B1 BR9915621B1 (pt) 2011-07-26

Family

ID=22736400

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9915621-0A BR9915621B1 (pt) 1998-11-24 1999-11-19 curativos.

Country Status (11)

Country Link
EP (1) EP1133325B1 (pt)
JP (1) JP4558208B2 (pt)
CN (1) CN1188176C (pt)
AR (1) AR021371A1 (pt)
AU (1) AU1825200A (pt)
BR (1) BR9915621B1 (pt)
CA (1) CA2350594A1 (pt)
CO (1) CO5100944A1 (pt)
DE (1) DE69930297T2 (pt)
WO (1) WO2000030694A1 (pt)
ZA (1) ZA200105134B (pt)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6455066B1 (en) 2000-03-10 2002-09-24 Epicept Corporation Intradermal-penetration agents for topical local anesthetic administration
CZ295826B6 (cs) * 2003-04-28 2005-11-16 Ústav Makromolekulární Chemie Av Čr Materiál pro krytí ran obsahující lapače radikálů
KR100510169B1 (ko) * 2003-11-25 2005-08-24 김택영 탈지면에 분리망이 형성된 메쉬코튼과 그 제조방법
JP2005168723A (ja) * 2003-12-10 2005-06-30 Nissei Kk 吸収性貼付シート
GB0410749D0 (en) * 2004-05-14 2004-06-16 Dow Corning Ireland Ltd Coating apparatus
US20060178609A1 (en) 2005-02-09 2006-08-10 Z-Medica, Llc Devices and methods for the delivery of molecular sieve materials for the formation of blood clots
CN101160143A (zh) 2005-02-15 2008-04-09 弗吉尼亚大学 用于急性止血、治疗急性损伤和慢性溃疡的矿物技术（mt）
US8938898B2 (en) 2006-04-27 2015-01-27 Z-Medica, Llc Devices for the identification of medical products
US7604819B2 (en) 2006-05-26 2009-10-20 Z-Medica Corporation Clay-based hemostatic agents and devices for the delivery thereof
US8202532B2 (en) 2006-05-26 2012-06-19 Z-Medica Corporation Clay-based hemostatic agents and devices for the delivery thereof
US7968114B2 (en) 2006-05-26 2011-06-28 Z-Medica Corporation Clay-based hemostatic agents and devices for the delivery thereof
PL2039328T3 (pl) * 2006-07-06 2014-07-31 Zuiko Corp Materiał do pokrywania ran
DE102007002073A1 (de) * 2007-01-09 2008-07-10 Matthias Habenicht Mittel zur Pflege und antimikrobiellen Behandlung der Haut
US8858969B2 (en) 2010-09-22 2014-10-14 Z-Medica, Llc Hemostatic compositions, devices, and methods
EP2532326B1 (de) * 2011-06-09 2016-03-30 Paul Hartmann AG Wundauflage, enthalted vliesstoff und salbengrundlage, zur unterdrucktherapie
IN2014DN11041A (pt) 2012-06-22 2015-09-25 Z Medica Llc
US9970303B2 (en) 2014-05-13 2018-05-15 Entrotech, Inc. Erosion protection sleeve
EP2995324A1 (en) * 2014-09-11 2016-03-16 Mölnlycke Health Care AB Medical dressing
JP2016198170A (ja) * 2015-04-08 2016-12-01 国立大学法人 鹿児島大学 創傷被覆材および創傷被覆材の製造方法
CN108136230B (zh) 2015-10-22 2022-05-13 宝洁公司 发泡膜的阻隔贴片和改善皮肤外观的方法
US9872816B2 (en) 2015-10-22 2018-01-23 The Procter & Gamble Company Barrier patch of a foamed film and methods of improving skin appearance
EP3364935B1 (en) 2015-10-22 2019-11-20 The Procter and Gamble Company Barrier patch of a foamed film and methods of improving skin appearance
DK3228329T3 (da) * 2016-04-06 2022-08-29 Upm Kymmene Corp Fremgangsmåde til fremkomst af et lægemiddel, omfattende nanofibrillar cellulose og et lægemiddel
CN105903056A (zh) * 2016-06-02 2016-08-31 四川奎星医用高分子制品有限责任公司 含有镇痛药物的医用复合海藻酸盐敷料及其制备方法
CN110049803B (zh) 2017-01-09 2022-06-07 宝洁公司 具有可溶性膜的阻隔贴片和改善皮肤外观的方法
US10857076B2 (en) 2017-01-09 2020-12-08 The Procter & Gamble Company Barrier patch with soluble film and methods of improving skin appearance
US10751265B2 (en) 2017-01-09 2020-08-25 The Procter & Gamble Barrier patch with soluble film and methods of improving skin appearance
US10959918B2 (en) 2017-06-22 2021-03-30 The Procter & Gamble Company Films including a water-soluble layer and a vapor-deposited coating
WO2019183010A1 (en) 2018-03-19 2019-09-26 The Procter & Gamble Company Method of making a barrier patch with soluble film
CN111249516B (zh) * 2018-12-01 2020-12-22 浙江大学 一种含胰蛋白酶的止血织物及其制备方法
CN112121146B (zh) * 2019-06-25 2021-08-06 山东瑞安药业有限公司 一种用于皮肤创伤的外用凝胶剂及其制备方法
CN110393634A (zh) * 2019-06-28 2019-11-01 孙秀梅 一种用于治疗动静脉穿刺术后皮下损伤的治疗膜

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4867150A (en) * 1987-01-20 1989-09-19 The B. F. Goodrich Company Perforated elastomeric soft film and wound dressing made therewith
DK158336C (da) * 1987-09-22 1990-10-01 Coloplast As Forbindsmateriale til behandling af saar samt smaalegemer til brug ved fremstilling deraf
GB8917790D0 (en) * 1989-08-03 1989-09-20 Smith & Nephew Adhesive dressing
US5681579A (en) * 1993-03-22 1997-10-28 E.R. Squibb & Sons, Inc. Polymeric support wound dressing
GB2276819B (en) * 1993-03-23 1996-12-11 Johnson & Johnson Medical Aqueous wound treatment composition comprising a polysaccharide and hexylene glycol
DE4416927C1 (de) * 1994-05-13 1995-08-31 Lohmann Therapie Syst Lts Vorrichtung zur Abgabe von Wirkstoffen aus Haftschmelzklebern, Verfahren zu ihrer Herstellung und ihre Verwendung
US5814031A (en) * 1995-03-02 1998-09-29 Mooney; Mark Structured occllusive dressings

Also Published As

Publication number Publication date
EP1133325B1 (en) 2006-03-08
DE69930297T2 (de) 2006-11-30
EP1133325A1 (en) 2001-09-19
DE69930297D1 (de) 2006-05-04
CO5100944A1 (es) 2001-11-27
AR021371A1 (es) 2002-07-17
JP2002530157A (ja) 2002-09-17
CA2350594A1 (en) 2000-06-02
AU1825200A (en) 2000-06-13
JP4558208B2 (ja) 2010-10-06
CN1328475A (zh) 2001-12-26
CN1188176C (zh) 2005-02-09
BR9915621B1 (pt) 2011-07-26
WO2000030694A1 (en) 2000-06-02
ZA200105134B (en) 2002-06-21

Similar Documents

Publication Publication Date Title
BR9915621A (pt) Revestimento útil como um distribuidor de um ingrediente ativo em curativos e ataduras
BR0109912A (pt) Novas combinações antelmìnticas
BR9911071A (pt) Preparações para aplicação de agentes antiinflamatórios, especialmente anti-sépticos e/ou agentes promotores da cura de feridas no trato respiratório superior e/ou no ouvido
YU7296A (sh) Farmaceutska kompozicija koja sadrži kombinaciju jedne protivvirusne supstance i jednog protivzapaljenskog glukokortikoida
BR9911076A (pt) Uso de peg-ifn-alfa e ribavirina para o tratamento de hepatite c crÈnica
BR0211673A (pt) Terapia dermal utilizando derivados de fosfato de agentes de transferência de elétrons
BR0112356A (pt) Formulações farmacêuticas tópicas e métodos de tratamento
BR0015604A (pt) Método para o tratamento de cicatrizes hipertróficas de modo a reduzir o tamanho e/ou melhorar a aparência das mesmas, composições para tratar condições adversas da pele, e, para reduzir o tamanho e melhorar a aparência de cicatrizes hipertróficas
BR0109336A (pt) Medicamento para a prevenção, melhora e/ou tratamento de uma complicação diabética, droga medicinal adequada ou utilizável como o mesmo, método para prevenir, melhorar e/ou tratar a complicação diabética, e a neuropatia, e, usos de um agente redutor do açúcar no sangue pós-prandial e pelo menos um agente selecionado de um agente anti-hipertensivo, um agente vasodilatador e um agente anti-hiperlipidêmico
US4788061A (en) Extended occlusive treatment of skin disorders
BR9611587A (pt) Processo e composição para tratamento da pele deseres humanos e preparação tópica para aplicação à pele.
CA2609104C (en) Method and device for treating bursitis
UA35567C2 (uk) Фармацевтичний препарат для лікування хворих з порушеннями функції коагуляції, спосіб лікування таких хворих, спосіб одержання фармацевтичного препарату
US5571535A (en) Treatment of topical infections
BR0116251A (pt) composição de lágrimas artificiais contendo uma combinação de três demulcentes
BR9810832B1 (pt) composição farmacêutica contendo como princìpios ativos vitamina d associada a um sal de cálcio, e, processos para a preparação de uma composição farmacêutica, para o tratamento de deficiências nutricionais de cálcio e vitamina d na velhice e para reduzir a perda de tecido ósseo ligada à idade e para evitar fraturas femurais e outras fraturas não vertebrais.
PT1069902E (pt) Utilizacao de fosfolipidos na producao de um medicamento para a prevencao de adesoes
BR9814214A (pt) Composição com ácido azeláico
WO1999026589A3 (en) Composition for the treatment of burns, sunburns, abrasions, ulcers and cutaneous irritation
DE69825279D1 (de) Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz
BR0316463A (pt) Administração dérmica de um inibidor seletivo de ciclooxigenase-2 solúvel em água, por exemplo, derivados de parecoxib, valdecoxib e benzopirano
BR0113372A (pt) Composição farmacêutica com carreador modificado, método de fabricação da mesma e seus usos
BR0012775A (pt) Comprimido de microgrânulos com baixa dosagem de princìpio ativo contendo um diluente diretamente compressìvel, composição, e, processo de preparação do comprimido
KR900007434A (ko) 시스타틴을 유효 성분으로하는 치료제
BR0309515A (pt) Curativos de ferimento condutivos e métodos de uso

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 26/07/2011, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 17A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2386 DE 27-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.